JSCN2022

Presentation information

Print

Platform Session

[EO-05] Platform Session 05：Neurodevelopmental Disorders

Thu. Jun 2, 2022 4:40 PM - 5:40 PM Room 6 (Medium Conference Room 202)

Chair: Ortiz Marilyn(Head and Consultant, Child Neurology Section, Chil),Koeda Tatsuya(National Center for Child Health and Development)

[EO-026] Therapeutic effects of bumetanide on neurological dysfunction in a mouse model of Angelman syndrome

Kiyoshi Egawa1，Hideaki Shiraishi1，James Cook2 (1. Department of Pediatrics, Hokkaido University Graduate School of Medicine，2. Drug Discovery and Development Faculty, University of Wisconsin Milwaukee)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password